Advertisement

Supplemental Material

The links to relevant recommendations of the American College of Obstetricians and Gynecologists are provided as the primary source of supplemental information to that provided in Clinical Updates in Women's Health Care monographs when applicable. The links to resources other than those of the American College of Obstetricians and Gynecologists are provided for information purposes only, and referral to these resources does not imply the endorsement of the American College of Obstetricians and Gynecologists.

Gynecologic and Obstetric Care for Breast Cancer Survivors (Vol XVI, No 4)

For ACOG guidelines on the use of aromatase inhibitors, refer to Aromatase inhibitors in gynecologic practice. ACOG Committee Opinion No. 738. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;131:e194-9.

For information about management of genitourinary syndrome of menopause, refer to Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause 2018;256:596-608.

For information about integrative therapies before and after breast cancer treatment, refer to Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol 2018:JCO2018792721.

For information on cardiovascular disease and breast cancer, refer to a scientific statement from the American Heart Association: Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

For additional information on breast cancer risk assessment, refer to Breast cancer risk assessment and screening in average-risk women. Practice Bulletin No. 179. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e1-16.

For additional information on hereditary breast and ovarian cancer syndrome, refer to Hereditary breast and ovarian cancer syndrome. Practice Bulletin No. 182. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e110-26.

For additional information on hereditary cancer syndromes and risk assessment, refer to Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1538-43.

For additional information on osteoporosis, refer to Osteoporosis. Practice Bulletin No. 129. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:718-34.

 




Editor
Russell R. Snyder, MD

Associate Editor
Anne E. Burke, MD

Past Editor
Raul Artal, MD

ISSN 1536-3619
Published 6 times per year